The elevated overall epidermal growth factor receptor (EGFR) kinase activity, as a result of the increased amount and/or the gain-of-function mutations, is largely responsible for the tumor malignancy in non-small cell lung cancer (NSCLC)3,4. Here, EGFR is linked to non-small cell lung carcinoma.